Nutraceutical International
This article was originally published in The Tan Sheet
Executive Summary
Firm announces acquisition of Castle Rock, Colo.-based firm Natural Balance for $9 mil. The acquisition brings a line of approximately 50 branded health and supplement products as well as "increased specialty product store penetration," according to Nutraceutical CEO Bill Gay. Natural Balance had pro forma net sales in excess of $10 mil. in 2003, according to the firm. Nutraceutical sales increased 23% to $37.6 mil. in the second quarter (ended March 31) with income up 20% to $4.2 mil...
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.